/Companies

BacterioScan

St. Louis, US · Founded 2010 · Delaware corporation

Find your way into BacterioScan

Sign up to see every warm intro you have to BacterioScan

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the BacterioScan team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Bacterioscan develops diagnostic technologies and solutions for bacterial detection and identification. The company serves healthcare, pharmaceutical, and diagnostics markets.

Founders & leadership

DA
Dana A. MarshallPresident and Chief Executive OfficerDana A. Marshall is President and CEO of BacterioScan, which develops diagnostic technologies for bacterial detection and identification. He has over 30 U.S. patents in medical devices, in-vitro diagnostics, lasers and optics, and photonic instrumentation, with prior experience in clinical, aerospace, defense, and manufacturing sectors.
MEMichael E. Thaman, Sr.
Michael E. Thaman, Sr.CEO & Chairman of the Board
RS
Rhonda SoestDirector of Marketing

Board

ME
Michael E. ThamanBoard director
AW
Amnon WeischelbaumBoard director
RR
Richard R. VietorBoard director
JB
James Brigham, Jr.Board director
WR
William R. MarshallBoard director
MB
Moshe BarkenBoard director

Reported raises · per SEC filings

Form D private placements

$7.4M disclosed across 2 rounds · 2013–2015

▶$1.7MraisedAug 2015 · 7 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard R. VietorDirector
  • Greg HewettDirector
  • Moshe BarkanDirector
  • Michael E. ThamanExecutive Officer, Director
  • Dana MarshallExecutive Officer, Director
Offering amount
$4M
Amount sold
$1.7M
First sale
Jul 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.7MraisedFeb 2015 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael E. ThamanDirector
  • Amnon WeischelbaumDirector
  • Richard R. VietorDirector
  • James Brigham, Jr.Director
  • William R. MarshallDirector
  • Dana A. MarshallExecutive Officer
  • Moshe BarkenDirector
  • Rhonda SoestExecutive Officer
Offering amount
$6M
Amount sold
$5.7M
Minimum investment
$150K
First sale
May 2013
Incorporated
Corporation, Delaware, 2010
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

Companies working in the same space as BacterioScan.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase I2018$210.9K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Frequently asked questions

What does BacterioScan do?
Bacterioscan develops diagnostic technologies and solutions for bacterial detection and identification. The company serves healthcare, pharmaceutical, and diagnostics markets.
How much funding has BacterioScan raised?
BacterioScan has disclosed $7.4M raised across 2 rounds.
Where is BacterioScan headquartered?
BacterioScan is headquartered in St. Louis, US.